Request Expert

Expert is Professor of Gynecology, Urogynecology, and Family Planning at Baylor College of Medicine with nearly 35 years of clinical, academic, and research experience. He is also Medical Director of a regional Planned Parenthood for the past 25 years. He is a Board Certified Ob/Gyn and former Fellowship Director of Urogynecology at his institution. He has published extensively on areas in gynecology, urogynecology, and family planning. He has been Principal Investigator in many large multi-site clinical national and international studies. He as been Principal Investigator for NIH funded research.

Currently, his primary work is focused on teaching and providing care at his urogynecology clinic where is is both a medical director as well as an administrator. As an administrator he coordinates medical student and resident rotations at at his urogynecology clinic as well as at the Planned Parenthood in his region.

His clinical research in obstetrics and gynecology has been on clinical trials testing for female pelvic floor disorders, comparing bone mineral density of women using Lunelle vrs. Pharmacia and UpJohn, Duloxitene HCL in the treatment of Mixed Urinary Incontinence, determining the efficacy and safety of a 21day Monophasic oral contraceptive preparation of Levonorgestrel and Ethinyl Estradiol, the safety and efficacy study of Desogestrel containing oral contraceptives, Desogen vrs. Lo Ovral, evaluating the efficacy and safety of Tibolone in the prevention of osteoporosis in the postmenopausal women, evaluating the Estradiol matrix transdermal therapeutic system in the prevention of postmenopausal bone loss, comparing vaginal cream in the treatment of vulvovaginal candidiasis, evaluating the clinical protocol to demonstrate the effectiveness and safety of Nafarelin Acetate and the treatment of endometriosis, comparing the effect of Loestrin vrs. Allesse, Duloxetine vrs. placebo in the relief of stress urinary incontinence, studying the safety and efficacy of PEN 203 in the treatment of external genital warts in females,and evaluating the quality of life in patients treated with Tolterodine. His clinical research has been sponsored and funded by several nationally recognized pharmaceutical companies and corporations as well as the National Institute of Health and 3M.

He is familiar with ProbeTec, stem cell studies regarding human fetal tissue, alcohol-exposed pregnancies, anogential warts, Ciproflaxocin Once Daily, Medroxy7progesterone Acetate and Estradiol Cypionate Injectable, Depo-Provera on bone mineral density, vaginal atrophy and Lasofoxifene, various STDs, abortion, NuvaRing, Plan B and other pharmaceutical treatment related to obstetrics and gynecologic issues. He has been invited to speak and give lectures and presentations on the various topics at several teaching hospitals and medical colleges throughout the United States.

Senior Consultant for Gearson Leahman Group (GLG)Senior Research Consultant for Planned Parenthood Federation of America